Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of ribosome synthesis 1 (RRS1) is a highly conserved nucleolar protein essential for ribosome biogenesis, where it enables binding to 5S rRNA and mediates maturation and assembly of the 60S ribosomal subunit[1][2][3][4]. RRS1 plays a central role in chromosome alignment during mitosis, is involved in cell cycle regulation, and stabilizes nucleolar structure by interacting with other ribosome biogenesis factors[1][3][4]. Aberrant expression of RRS1 has been observed in multiple cancers, including hepatocellular carcinoma and breast cancer, where it facilitates oncogenic transformation by supporting rapid cell proliferation and suppressing p53-mediated growth arrest[1][3][5]. RRS1 dysfunction is also implicated in neurodegeneration and other diseases through its effects on ribosome assembly and cellular homeostasis[1]. No direct drugs targeting RRS1 are currently described in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of ribosome synthesis 1 (RRS1).